BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9675375)

  • 1. Pharmacokinetics and pharmacodynamics in anesthetic drug development.
    Shafer SL
    Acta Anaesthesiol Belg; 1998; 49(2):65-78. PubMed ID: 9675375
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats.
    Pypendop BH; Brosnan RJ; Majewski-Tiedeken CR; Stanley SD; Ilkiw JE
    J Vet Pharmacol Ther; 2014 Feb; 37(1):13-7. PubMed ID: 23895731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics, pharmacokinetics, and clinical uses of fentanyl, sufentanil, and alfentanil.
    Willens JS; Myslinski NR
    Heart Lung; 1993; 22(3):239-51. PubMed ID: 8387987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of remifentanil in clinical anesthesia.
    Philip BK
    Acta Anaesthesiol Scand Suppl; 1996; 109():170-3. PubMed ID: 8901996
    [No Abstract]   [Full Text] [Related]  

  • 5. Basic principles of pharmacokinetics and pharmacodynamics for the anesthesiologist.
    Camu F; Lauwers M; Vanlersberghe C
    Acta Anaesthesiol Belg; 1998; 49(2):55-64. PubMed ID: 9675374
    [No Abstract]   [Full Text] [Related]  

  • 6. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness.
    Vuyk J; Mertens MJ; Olofsen E; Burm AG; Bovill JG
    Anesthesiology; 1997 Dec; 87(6):1549-62. PubMed ID: 9416739
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics, and rational opioid selection.
    Shafer SL; Varvel JR
    Anesthesiology; 1991 Jan; 74(1):53-63. PubMed ID: 1824743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total intravenous anaesthesia (TIVA) in paediatrics: advantages and disadvantages.
    Morton NS
    Paediatr Anaesth; 1998; 8(3):189-94. PubMed ID: 9608961
    [No Abstract]   [Full Text] [Related]  

  • 10. Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.
    Langevin S; Lessard MR; Trépanier CA; Baribault JP
    Anesthesiology; 1999 Dec; 91(6):1666-73. PubMed ID: 10598609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sufentanil. An alternative to fentanyl/alfentanil?].
    Ellmauer S
    Anaesthesist; 1994 Mar; 43(3):143-58. PubMed ID: 8179164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria.
    Hanouz JL; Yvon A; Guesne G; Eustratiades C; Babatasi G; Rouet R; Ducouret P; Khayat A; Bricard H; Gérard JL
    Anesth Analg; 2001 Sep; 93(3):543-9. PubMed ID: 11524316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative effectiveness of fentanyl and its newer analogs during extracorporeal shock wave lithotripsy under monitored anesthesia care.
    Gesztesi Z; Rego MM; White PF
    Anesth Analg; 2000 Mar; 90(3):567-70. PubMed ID: 10702438
    [No Abstract]   [Full Text] [Related]  

  • 14. Accidental injection of remifentanil can cause a much more dangerous situation than the same dose of fentanyl.
    Kunisawa T; Nagashima M; Suzuki A; Takahata O; Iwasaki H
    J Anesth; 2010 Dec; 24(6):970-1. PubMed ID: 20721610
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the pharmacokinetics and pharmacodynamics of remifentanil.
    Glass PSA; Gan TJ; Howell S
    Anesth Analg; 1999 Oct; 89(4 Suppl):7. PubMed ID: 10511072
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remifentanyl: pharmacokinetics, pharmacodynamics, use].
    Mizikov VM; Lovtsevich NV; Rudenko MV; Vereshchagina II
    Anesteziol Reanimatol; 1999; (6):19-22. PubMed ID: 11452762
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
    Lemmens HJ; Dyck JB; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1994 Sep; 56(3):261-71. PubMed ID: 7924121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.
    Ummenhofer WC; Arends RH; Shen DD; Bernards CM
    Anesthesiology; 2000 Mar; 92(3):739-53. PubMed ID: 10719953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil.
    Cascone S; Lamberti G; Piazza O; Abbiati RA; Manca D
    Eur J Pharm Sci; 2018 Jan; 111():20-28. PubMed ID: 28939143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of newer opioids in geriatric anesthesia.
    Shafer SL
    Acta Anaesthesiol Belg; 1998; 49(2):91-103. PubMed ID: 9675378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.